Call for proposals to support the development of a medicine pricing, reimbursement and access tracker through the EURIPID database
Funds the development of an EU-wide tracker for medicine pricing, reimbursement, and access using the EURIPID database to improve data quality, transparency, and informed decision-making on medicine availability.
This grant is no longer accepting proposals
European Commission has archived this opportunity.
Funder: European Commission
Due Dates: January 6, 2026 (Full application deadline)
Funding Amounts: €750,000 total call budget; typically one grant awarded, project duration up to 36 months, 60% funding rate (up to 80% for exceptional utility)
Summary: Supports the development of a medicine pricing, reimbursement, and access tracker via the EURIPID database to enhance data quality and inform access to medicines across the EU.
Key Information: Only authorities competent in pricing/reimbursement of medicines from EURIPID member states are eligible to coordinate.
Description
This grant, under the EU4Health Programme, aims to fund the development and implementation of a comprehensive medicine pricing, reimbursement (P&R), and access tracker using the EURIPID database. The project is expected to deliver a robust platform that collects, analyses, and disseminates national-level data on early access schemes, P&R applications, decisions, and criteria, as well as access dashboards based on OECD indicators. The initiative will also facilitate automated data sharing with Member States, enhance interoperability with other European health data platforms, and produce annual trend analysis reports on access to medicines. The overall goal is to support better decision-making by national authorities, improve data quality and coverage, and ultimately increase the availability, accessibility, and affordability of medicines across the EU.
